Du, Y., Qi, Z. ., Liang , X. ., Dai, J. ., Wei , X. ., Bai , X. ., Mao, L. ., Chi , Z. ., Cui, C. ., Lian, B. ., Tang , B. ., Wang , X. ., Chen , Y. ., Guo , J. ., & Si, L. (2024). Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study . Dermatology Practical & Conceptual, 14(1), e2024026. https://doi.org/10.5826/dpc.1401a26